Added to YB: 2018-12-21
Pitch date: 2018-12-21
EXEL:US [bullish]
Exelixis, Inc.
+134.4%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
Market Cap
$11.3B
Pitch Price
$17.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
11.22
P/E
17.73
EV/Sales
4.35
Sector
Biotechnology
Category
N/A
Show full summary:
EXELIXIS INC COM EXEL:US
A summary for this pitch has not been created yet.
Read full article (0 min)